Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
This study investigates the effects of astaxanthin (ASX) on insulin signaling and glucose metabolism in the liver of mice fed a high fat and high fructose diet (HFFD). Adult male Mus musculus mice of body mass 25–30 g were fed either normal chow or the HFFD. After 15 days, mice in each group were subdivided among 2 smaller groups and treated with ASX (2 mg·(kg body mass)–1) in olive oil for 45 days. At the end of 60 days, HFFD-fed mice displayed insulin resistance while ASX-treated HFFD animals showed marked improvement in insulin sensitivity parameters. ASX treatment normalized the activities of hexokinase, pyruvate kinase, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glycogen phosphorylase, and increased glycogen reserves in the liver. Liver tissue from ASX-treated HFFD-fed animals showed increased tyrosine phosphorylation and decreased serine phosphorylation of insulin receptor substrates (IRS)-1 and -2. ASX increased IRS 1/2 and phosphatidylinositol 3-kinase (PI3K) association and serine phosphorylation of Akt. In addition, ASX decreased HFFD-induced serine kinases (c-jun N-terminal kinase-1 and extracellular signal-regulated kinase-1). The results suggest that ASX treatment promotes the IRS–PI3K–Akt pathway of insulin signaling by decreasing serine phosphorylation of IRS proteins, and improves glucose metabolism by modulating metabolic enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 5×
“Parameters CON HFFD HFFD ASX CON ASX Initial body mass (g) 26.5 0.67 27.5 0.58 27.9 0.89 27.0 0.87 Final body mass (g) 30.5 0.71 35.7 0.76* 32.5 0.82** 31.7 0.98 Glucose (mg·dL–1) 81.8 4.52 132.8 8.98* 96.7 4.74** 80.6 4.74 Insulin ( U·mL–1) 15.4 1.46 28.5 2.63* 20.2 1.76** 16.6 0.96 HOMA 0.51 0.002 1.55 0.008* 0.81 0…”
MethodInfluentialA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Haematococcus astaxanthin: applications for human health and nutrition
Guerin, M., Huntley, M. E., & Olaizola, M. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(03)00078-7 · Cited by 1,495
Dietary fat intake does affect obesity!
Bray, G. A., & Popkin, B. M. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1157 · Cited by 1,123 · cited 1×
“The consumption of a high calorie diet that is rich in both fat and refined sugar is suggested to be a key factor that accounts for the rising prevalence of insulin resistance, obesity, and type-2 diabetes (Bray and Popkin 1998; Elliott et al. 2002; Bray et al. 2004).”
BackgroundFructose, weight gain, and the insulin resistance syndrome,,
Elliott, S. S., Keim, N. L., Stern, J. S., Teff, K., & Havel, P. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.911 · Cited by 1,039
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“Phosphorylation of ser residues of IRS-1 and IRS-2 blocks tyrosine (tyr) phosphorylation by inhibiting the interaction of the adjacent phosphotyrosine (p-Y)-binding domain with the phosphorylated NPEY motif in the activated insulin receptor (Aguirre et al. 2002).”
BackgroundDevelopment of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats
Kraegen, E. W., Clark, P. W., Jenkins, A. B., Daley, E. A., Chisholm, D. J., & Storlien, L. H. (1991) · Diabetes · doi:10.2337/diab.40.11.1397 · Cited by 601 · cited 1×
“Hepatic insulin resistance precedes peripheral insulin resistance during the administra- tion of such unbalanced diets (Kraegen et al. 1991; Pagliassotti et al. 1996; Thresher et al. 2000).”
BackgroundAstaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans
Park, J. S., Chyun, J. H., Kim, Y. K., Line, L. L., & Chew, B. P. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-18 · Cited by 569
Effects of astaxanthin in obese mice fed a high-fat diet
IKEUCHI, M., KOYAMA, T., TAKAHASHI, J., & YAZAWA, K. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60521 · Cited by 222 · cited 1×
“Previous studies have demostrated anti-obesity effects of ASX in mice fed a high fat diet (Ikeuchi et al. 2007), and antidiabetic effects in db/db mice (Uchiyama et al. 2002).”
BackgroundVitamin E improves the action of insulin
Caballero, B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1993.tb03761.x · Cited by 61
Cited by
Astaxanthin: A mechanistic review on its biological activities and health benefits
Fakhri, S., Abbaszadeh, F., Dargahi, L., & Jorjani, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.012 · Cited by 461
Ursoniu, S., Sahebkar, A., Serban, M.-C., & Banach, M. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.50960 · Cited by 80
Gao, X., Xu, J., Jiang, C., Zhang, Y., Xue, Y., Li, Z., Wang, J., Xue, C., & Wang, Y. (2015) · Food & Function · doi:10.1039/c5fo00007f · Cited by 60
Sun, L., Miyaji, N., Yang, M., Mills, E. M., Taniyama, S., Uchida, T., Nikawa, T., Li, J., Shi, J., Tachibana, K., et al. (2021) · Nutrients · doi:10.3390/nu13020379 · Cited by 45
Metadata
- Authors
- Bhuvaneswari, S., & Anuradha, C. V.
- Venue
- Canadian Journal of Physiology and Pharmacology
- Publisher
- Canadian Science Publishing
- Published
- 2012-11
- Volume
- 90
- Issue
- 11
- Pages
- 1544-1552
- ISSN
- 0008-4212 (ISSN-L)
- 1205-7541
- OpenAlex
- W2089370698
- Cited by
- 107
- References
- 10
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. https://app.cochat.ai/papers/10.1139/y2012-119
- The paper
- Bhuvaneswari, S., & Anuradha, C. V. (2012). Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/y2012-119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.